VRDN
Viridian Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$22.92
−0.17%Leverage
- Debt / equity
- 0.37x
- Net debt / equity
- 0.12x
- Debt / assets
- 0.22x
- Debt / EBITDA
- -0.66x
- Net debt / EBITDA
- -0.21x
Liquidity & coverage
- Current ratio
- 16.95x
- Quick ratio
- 16.95x
- Cash ratio
- 15.39x
- Interest coverage
- -21.40x
- EBITDA / interest
- -19.43x
- Working capital
- $1.0B
Cash & dividend
- FCF / debt
- -1.38x
- Cash flow / debt
- -1.37x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026